MGTX
NASDAQ · Biotechnology
Meiragtx Holdings Plc
$9.49
-0.22 (-2.22%)
Open$9.65
Previous Close$9.71
Day High$9.70
Day Low$9.30
52W High$15.35
52W Low$6.62
Volume—
Avg Volume639.1K
Market Cap894.64M
P/E Ratio11.33
EPS$0.71
SectorBiotechnology
Analyst Ratings
Strong Buy
13 analysts
Price Target
+564.0% upside
Current
$9.49
$9.49
Target
$63.01
$63.01
$47.40
$63.01 avg
$83.78
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 98.29M | 57.06M | 298.22M |
| Net Income | -137,926,162 | -72,057,552 | -30,982,952 |
| Profit Margin | -140.3% | -133.3% | -10.4% |
| EBITDA | -127,619,827 | -70,377,219 | -39,492,333 |
| Free Cash Flow | — | — | -35,501,473 |
| Rev Growth | +72.3% | +72.3% | -0.7% |
| Debt/Equity | 1.08 | 1.08 | 0.77 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.31 | +1.07% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $460.42 | +0.03% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $166.89 | -0.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $547.09 | +0.85% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $904.35 | +0.16% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $155.94 | -0.46% | 7.7 | 20.98B |